Antigen-presenting type-I conventional dendritic cells facilitate curative checkpoint blockade immunotherapy in pancreatic cancer
K. K. Mahadevan, A. M. Dyevoich, Y. Chen, B. Li, H. Sugimoto, A. M. Sockwell, K. M. McAndrews, H. Wang, S. Shalapour, S. S. Watowich, R. Kalluri
The paper shows that type-I conventional dendritic cells enhance checkpoint blockade immunotherapy effectiveness in pancreatic cancer when combined with pancreatitis.
bioRxiv · Mar 5, 2023 · PreprintCancer Biology